CYCN - Cyclerion Therapeutics Inc
Previous close
3.15
0 0%
Share volume: 292
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.15
0.00
0.00%
Summary score
30%
Profitability
25%
Dept financing
11%
Liquidity
50%
Performance
35%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-40.82%
Return on assets
-26.33%
Return on sales
-5466.44%
Return on invested capital
106.73%
Total debt ratio
36.53%
Debt ratio change over timeo
-1.29%
Current Ratio
3.94%
Quick Ratio
3.84%
Cash Position Ratio
3.74%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-67.16%
Return on assets
-40.49%
Return on sales
-1208.55%
Return on invested capital
196.83%
Total debt ratio
43.08%
Debt ratio change over timeo
-0.92%
Current Ratio
2.18%
Quick Ratio
2.18%
Cash Position Ratio
1.93%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
58.77%
Return on assets
-17.82%
Return on sales
0%
Return on invested capital
251.45%
Total debt ratio
15.39%
Debt ratio change over time
-1.44%
Current Ratio
4.21%
Quick Ratio
4.21%
Cash Position Ratio
3.89%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-106.46%
Return on assets
-95.09%
Return on sales
4530.21%
Return on invested capital
-57.57%
Total debt ratio
-128.83%
Debt ratio change over time
-1.29%
Current Ratio
-4.26%
Quick Ratio
-3.54%
Cash Position Ratio
-4.09%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CYCN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -40.82% | 7.58% | 36.15% | 7.75% |
| Return on assets | -26.33% | 2.95% | 3.44% | 5.85% |
| Return on sales | -5466.44% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | 106.73% | 3.7% | 6.05% | 20.44% |
| Profitability | 25% | 37% | 62% | 60% |
| Total debt ratio | 36.53% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | -1.29% | 292.67% | 15.45% | 1.02% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 2.18% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 2.18% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 1.93% | 0.3% | 1.72% | 2.75% |
| Liquididy | 73% | 18% | 28% | 61% |
| Short-term ratios | CYCN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -67.16% | 11.57% | 35.05% | 4.21% |
| Return on assets | -40.49% | 2.86% | 2.7% | 3.6% |
| Return on sales | -1208.55% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | 196.83% | 2.16% | 6.93% | 9.79% |
| Profitability | 25% | 49% | 68% | 54% |
| Total debt ratio | 43.08% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | -0.92% | 102.83% | 13.09% | 1.3% |
| Dept financing | 12% | 49% | 28% | 6% |
| Current Ratio | 2.18% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 2.18% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 1.93% | 0.3% | 1.72% | 2.75% |
| Liquididy | 40% | 12% | 40% | 75% |